Clinical and pharmacological group: & nbsp

Antiseptics and disinfectants

Included in the formulation
  • Falimint®
    pills inwards 
    BERLIN-PHARMA, CJSC     Russia
  • АТХ:

    R.02.A.A   Antiseptics

    Pharmacodynamics:

    The action of the drug is similar to the action of menthol: it causes a feeling of coolness and freshness in the mouth and pharynx (with resorption), reduces the unproductive irritating cough. Does not exert a drying effect on the mucous membranes, does not cause a feeling of numbness in the mouth.

    When performing medical manipulations in the oral cavity, there may be a urge to vomit. The drug, due to its own calming effect, suppresses these desires.

    Pharmacokinetics:

    The active substance is well absorbed by the mucous surface of the digestive tract. The maximum concentration of acetylaminonitropropoxybenzene in the blood plasma is detected 0.5-1 hour after taking the drug. Due to the high solubility in lipids and low solubility in water, acetylaminonitropropoxybenzene is excreted from the body with urine in a metabolized form.

    The concentration of metabolites reaches its maximum value in urine after 2 hours. Within 6 hours the main amount of metabolites is eliminated. After 24 hours in the urine, about 95% of the administered dose is found in the form of metabolites, in terms of the main metabolite - (3- (2-acetamino-4-nitro-phenoxy) propionic acid).

    Indications:

    Inflammatory diseases of the respiratory tract (tonsillitis, pharyngitis, laryngitis); inflammatory diseases of the oral cavity (gingivitis, stomatitis); reflex cough (unproductive, irritating); preparation for instrumental studies of the oral cavity and throat, the removal of molds and the fitting of dentures.

    X.J00-J06.J02.9   Acute pharyngitis, unspecified

    X.J00-J06.J03.9   Acute tonsillitis, unspecified

    X.J00-J06.J04   Acute laryngitis and tracheitis

    XI.K00-K14.K05   Gingivitis and periodontal disease

    XVIII.R00-R09.R05   Cough

    XXI.Z40-Z54.Z46.3   Fitting and fitting the denture device

    XI.K00-K14.K12   Stomatitis and related lesions

    Contraindications:

    Hypersensitivity, pregnancy, breast-feeding, sucrose / isomaltose deficiency, fructose intolerance, glucosogalactose malabsorption, children under 5 years.

    Carefully:

    Do not apply for a long time!

    Pregnancy and lactation:

    Category of recommendations for Food and Drug Administration (US Food and Drug Administration) not determined. Adequate and well-controlled studies on humans and animals have not been conducted. Do not apply!

    Dosing and Administration:

    For 25-50 mg 3-5 times a day (no more than 10 dragees), without chewing, keep in the mouth until it resorbs. The maximum daily dose of 10 dragees.

    Side effects:

    Individual intolerance is possible.

    Overdose:

    Symptoms of overdose are not described. Treatment is symptomatic.

    Interaction:

    Drug interaction of the drug has not been described to date.

    Immediately after use, refrain from eating food and liquids.

    Special instructions:

    Do not use for prolonged use. It is not recommended to use the drug for more than 5 days without consulting a doctor.

    Efficacy and safety of use in children have not been studied. The funds for the throat act only on bacteria, so if the inflammatory diseases of the mouth, larynx or pharynx are caused by viruses or fungi, then these drugs will be ineffective.

    Instructions
    Up